KENNETH M. BRINKHOUS 
503 
33. Wagner, R. H., and Thelin, G. M. Antihemophilic 
factor: Current status of purification, chemical and 
physical characterization. In : Hemophilia and Hemo- 
philioid Diseases. Edited by K. M. Brinkhous, Uni- 
versity of North Carolina Press, Chapel Hill, p. 3, 
1957. 
34. Thelin, G. M., and Wagner, R. H. Sedimentation 
of plasma antihemophilic factor. Arch. Biochem. 
Biophys. 95:70, 1961. 
35. Webster, W. P., Roberts, H. R., Thelin, G. M., 
Wagner, R. H., and Brinkhous, K. M. Clinical 
use of a new glycine-precipitated antihemophilic 
fraction. Amer. J. Med. Sci. 250:643, 1965. 
36. Brinkhous, K. M., Shanbrom, E., Roberts, H. 
R., Webster, W. P., Fekete, L., and Wagner, R. 
H. A new high-potency glycine-precipitated anti- 
hemophilic factor (AHF) concentrate. J. A. M. A. 
205:618, 1968. 
37. Brinkhous, K. M. Plasma antihemophilic factor, 
biological and clinical aspects. Sang 25:738, 1954. 
38. Hershgold, E. J., Pool, J. G., and Pappenhagen, 
A. R. The potent antihemophilic globulin concen- 
trate derived from a cold insoluble fraction of 
human plasma: Characterization and further data 
on preparation and clinical trial. J. Lab. Clin. Med. 
67:23, 1966. 
39. Molester, W. D., and Wagner, R. H. Antibody 
to antihemophilic factor and its lack of reaction 
with hemophilic plasma. Amer. J. Physiol. 208:499, 
1965. 
